US 9303012B2
· Bendels et al.
· 2016
[cited by applicant]
US 9321727B2
· Bissantz et al.
· 2016
[cited by applicant]
US 9403808B2
· Bissantz et al.
· 2016
[cited by applicant]
US 9409866B2
· Grether et al.
· 2016
[cited by applicant]
US 9512141B2
· Dhurwasulu et al.
· 2016
[cited by applicant]
US 9522886B2
· Frei et al.
· 2016
[cited by applicant]
US 20080280868A1
· Eatherton et al.
· 2008
[cited by applicant]
CL 2020002927A1
· 2021
[cited by applicant]
CN 1703402A
· 2005
[cited by applicant]
CN 101522644A
· 2009
[cited by applicant]
CN 103608332A
· 2014
[cited by applicant]
CN 104024232A
· 2014
[cited by applicant]
CN 104837830A
· 2015
[cited by applicant]
CN 104854092A
· 2015
[cited by applicant]
CN 106132958A
· 2016
[cited by applicant]
CN 106349156A
· 2017
[cited by applicant]
CN 106458984A
· 2017
[cited by applicant]
CO 6890101A2
· 2014
[cited by applicant]
CO 2017005374A
· 2017
[cited by applicant]
ES 2388833T3
· 2012
[cited by applicant]
JP 2014516071A
· 2014
[cited by applicant]
JP 2014534210A
· 2014
[cited by applicant]
JP 2016501240A
· 2016
[cited by applicant]
JP 2017509688A
· 2017
[cited by applicant]
RU 2612138C2
· 2017
[cited by applicant]
WO 9504045A1
· 1995
[cited by applicant]
WO 2012168350A1
· 2012
[cited by applicant]
WO 2013060751A1
· 2013
[cited by applicant]
WO 2014086705A1
· 2014
[cited by applicant]
WO 2014086805A1
· 2014
[cited by applicant]
WO 2014086806A1
· 2014
[cited by applicant]
WO 2014086807A1
· 2014
[cited by applicant]
WO 2014154612A1
· 2014
[cited by applicant]
WO 2015150438A1
· 2015
[cited by applicant]
WO 2015150440A1
· 2015
[cited by applicant]
WO 2016066534A1
· 2016
[cited by applicant]
WO 2017097732A1
· 2017
[cited by applicant]
WO 2018234284A1
· 2018
[cited by applicant]
WO 2020002320A1
· 2020
[cited by applicant]
Communication Pursuant to Article 94(3) EPC for European Application No. 19733484.0, mailed on Sep. 23, 2022, 6 pages.
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/EP2019/066799, mailed on Jul. 10, 2019, 11 pages.
[cited by applicant]
International Search Report and Written Opinion issued in International Application No. PCT/EP2019/066811, mailed on Aug. 8, 2019, 10 pages.
[cited by applicant]
Search Report for Russian Application No. 2021101106/04(002123), mailed on Aug. 23, 2022, 2 pages.
[cited by applicant]
Belikov, V.G. (2007) “Pharmaceutical Chemistry”, Moscow: MEDpress-Inform, 13 pages.
[cited by applicant]
Haider et al. (2020) “Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors”, …
[cited by applicant]
Haider et al. (2019) “Structure-Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors”, Journal o…
[cited by applicant]
Pacher et al. (2011) “Is Lipid Signaling Through Cannabinoid 2 Receptors Part of a Protective System?”, Progress in lipid research, 50(2):193-211.
[cited by applicant]
Pitt et al. (1975) “The Synthesis of Deuterium, Carbon-14, and Carrier-free Tritium Labeled Cannabinoids”, Journal of Labelled Compounds, 11(4):551-575.
[cited by applicant]
Slavik et al. (May 7, 2015) “Discovery of a High Affinity and Selective Pyridine Analog as a Potential Positron Emission Tomography Imaging Agent for Cannabinoid Type 2 Receptor”, Journal of Medicinal Chemistry, 58 (10)…
[cited by applicant]